{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:44:16Z","timestamp":1783957456694,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003945","name":"Link\u00f6ping University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003945","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background and aim<\/jats:title>\n            <jats:p>Dysglycaemia is a known risk factor for cardiovascular disease and microcirculatory dysfunction is associated with an increased cardiovascular disease risk. The aim of this study was to investigate the prevalence of impaired microcirculation, coronary atherosclerosis, and arterial stiffness in individuals with normo- and dysglycaemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The study included 3,300 participants with microcirculatory measurements and information on glycaemic status, aged 50\u201365 years, from the Link\u00f6ping site of the Swedish CArdio-Pulmonary bioImage Study (SCAPIS). Microvascular function was assessed in forearm skin using an arterial occlusion and release protocol determining peak blood oxygen saturation (OxyP). Data on pulse wave velocity (PWV) and the Coronary Artery Calcification Score (CACS) were collected. Participants were categorised into three glycaemic categories: normoglycaemia, prediabetes and diabetes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>OxyP was lower in the prediabetes group \u2212\u20091.2%-units, 95% CI (-1.8 to -0.6) and in study participants with diabetes \u2212\u20092.4%-units, 95% CI (-3.1 to -1.6) compared to the normoglycaemic group 84.3%, 95% CI (83.6 to 84.9). PWV and CACS were higher in participants with dysglycaemia. Prevalent impaired function at three vascular levels (lowest quartile of OxyP\u2009+\u2009PWV\u2009\u2265\u200910\u00a0m\/s and CACS\u2009\u2265\u2009100) were observed in 0.8%, 2.3% and 7.6% in the glycaemic categories respectively. The difference between the normoglycaemic and the diabetes category and the difference between the pre-diabetes and the diabetes category was significant, p\u2009=\u2009&lt;\u20090.05.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Patients with prediabetes and diabetes are more likely to have impaired microcirculation in the forearm skin and macrovascular disorders such as arterial stiffness and atherosclerosis in the coronary arteries compared to normoglycaemic individuals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s12933-025-02628-5","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:29:59Z","timestamp":1740155399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impaired microcirculation in the skin and subclinical atherosclerosis in individuals with dysglycaemia in a large population-based cohort"],"prefix":"10.1186","volume":"24","author":[{"given":"John","family":"Cederqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"R\u00e5dholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik H.","family":"Nystrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Engvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bergstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingemar","family":"Fredriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Str\u00f6mberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Johan","family":"\u00d6stgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"issue":"1","key":"2628_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s10020-018-0060-3","volume":"24","author":"SL Fishman","year":"2018","unstructured":"Fishman SL, et al. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Mol Med. 2018;24(1):59.","journal-title":"Mol Med"},{"key":"2628_CR2","doi-asserted-by":"publisher","first-page":"p7839101","DOI":"10.1155\/2017\/7839101","volume":"2017","author":"D Huang","year":"2017","unstructured":"Huang D, et al. Macrovascular complications in patients with diabetes and Prediabetes. Biomed Res Int. 2017;2017:p7839101.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2628_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12933-016-0487-1","volume":"16","author":"D Fuchs","year":"2017","unstructured":"Fuchs D, et al. The association between diabetes and dermal microvascular dysfunction non-invasively assessed by laser doppler with local thermal hyperemia: a systematic review with meta-analysis. Cardiovasc Diabetol. 2017;16(1):11.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"2628_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/1479164117707706","volume":"14","author":"H Jonasson","year":"2017","unstructured":"Jonasson H, et al. Skin microvascular endothelial dysfunction is associated with type 2 diabetes independently of microalbuminuria and arterial stiffness. Diab Vasc Dis Res. 2017;14(4):363\u201371.","journal-title":"Diab Vasc Dis Res"},{"issue":"4","key":"2628_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00125-007-0918-3","volume":"51","author":"CD Stehouwer","year":"2008","unstructured":"Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008;51(4):527\u201339.","journal-title":"Diabetologia"},{"issue":"11","key":"2628_CR6","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.jdiacomp.2017.07.010","volume":"31","author":"A Tentolouris","year":"2017","unstructured":"Tentolouris A, et al. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus. J Diabetes Complications. 2017;31(11):1624\u20139.","journal-title":"J Diabetes Complications"},{"issue":"9324","key":"2628_CR7","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/S0140-6736(02)09089-X","volume":"359","author":"A Norhammar","year":"2002","unstructured":"Norhammar A, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359(9324):2140\u20134.","journal-title":"Lancet"},{"issue":"12","key":"2628_CR8","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","volume":"65","author":"MJ Davies","year":"2022","unstructured":"Davies MJ, et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022;65(12):1925\u201366.","journal-title":"Diabetologia"},{"key":"2628_CR9","doi-asserted-by":"crossref","unstructured":"Bergstrand S et al. Association between cardiovascular risk profile and impaired microvascular function in a Swedish middle-aged cohort (the SCAPIS study). Eur J Prev Cardiol, 2024.","DOI":"10.1093\/eurjpc\/zwae052"},{"key":"2628_CR10","doi-asserted-by":"publisher","first-page":"104284","DOI":"10.1016\/j.mvr.2021.104284","volume":"140","author":"H Jonasson","year":"2022","unstructured":"Jonasson H, et al. Post-ischemic skin peak oxygen saturation is associated with cardiovascular risk factors: a Swedish cohort study. Microvasc Res. 2022;140:104284.","journal-title":"Microvasc Res"},{"issue":"1","key":"2628_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12933-018-0703-2","volume":"17","author":"WD Strain","year":"2018","unstructured":"Strain WD, Pald\u00e1nius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17(1):57.","journal-title":"Cardiovasc Diabetol"},{"key":"2628_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12933-016-0385-6","volume":"15","author":"N \u00d6stlund Papadogeorgos","year":"2016","unstructured":"\u00d6stlund Papadogeorgos N, et al. Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome. Cardiovasc Diabetol. 2016;15:66.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2628_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12933-021-01290-x","volume":"20","author":"R de Ritter","year":"2021","unstructured":"de Ritter R, et al. Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: the Maastricht Study. Cardiovasc Diabetol. 2021;20(1):102.","journal-title":"Cardiovasc Diabetol"},{"issue":"18","key":"2628_CR14","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1161\/CIRCULATIONAHA.116.023446","volume":"134","author":"BM S\u00f6rensen","year":"2016","unstructured":"S\u00f6rensen BM, et al. Prediabetes and type 2 diabetes are Associated with generalized microvascular dysfunction: the Maastricht Study. Circulation. 2016;134(18):1339\u201352.","journal-title":"Circulation"},{"issue":"12","key":"2628_CR15","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.121.055340","volume":"144","author":"G Bergstr\u00f6m","year":"2021","unstructured":"Bergstr\u00f6m G, et al. Prevalence of subclinical coronary artery atherosclerosis in the General Population. Circulation. 2021;144(12):916\u201329.","journal-title":"Circulation"},{"issue":"6","key":"2628_CR16","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/joim.12384","volume":"278","author":"G Bergstr\u00f6m","year":"2015","unstructured":"Bergstr\u00f6m G, et al. The Swedish CArdioPulmonary BioImage Study: objectives and design. J Intern Med. 2015;278(6):645\u201359.","journal-title":"J Intern Med"},{"issue":"2","key":"2628_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino F, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255\u2013323.","journal-title":"Eur Heart J"},{"issue":"12","key":"2628_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1117\/1.JBO.23.12.121608","volume":"23","author":"H Jonasson","year":"2018","unstructured":"Jonasson H, et al. In vivo characterization of light scattering properties of human skin in the 475- to 850-nm wavelength range in a Swedish cohort. J Biomed Opt. 2018;23(12):1\u20136.","journal-title":"J Biomed Opt"},{"issue":"1","key":"2628_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1549-8719.2011.00129.x","volume":"19","author":"M Roustit","year":"2012","unstructured":"Roustit M, Cracowski JL. Non-invasive assessment of skin microvascular function in humans: an insight into methods. Microcirculation. 2012;19(1):47\u201364.","journal-title":"Microcirculation"},{"issue":"3","key":"2628_CR20","first-page":"1105","volume":"10","author":"JL Cracowski","year":"2020","unstructured":"Cracowski JL, Roustit M. Hum Skin Microcirculation Compr Physiol. 2020;10(3):1105\u201354.","journal-title":"Hum Skin Microcirculation Compr Physiol"},{"issue":"6","key":"2628_CR21","doi-asserted-by":"publisher","first-page":"H2250","DOI":"10.1152\/ajpheart.00545.2002","volume":"283","author":"A Koller","year":"2002","unstructured":"Koller A, Bagi Z. On the role of mechanosensitive mechanisms eliciting reactive hyperemia. Am J Physiol Heart Circ Physiol. 2002;283(6):H2250\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"2628_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.17925\/HI.2020.14.2.76","volume":"14","author":"J Beverly","year":"2020","unstructured":"Beverly J, Budoff MJ. Use of Coronary computed tomography for calcium screening of atherosclerosis. Heart Int. 2020;14(2):76\u20139.","journal-title":"Heart Int"},{"issue":"2","key":"2628_CR23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1148\/radiol.2432050808","volume":"243","author":"CH McCollough","year":"2007","unstructured":"McCollough CH, et al. Coronary artery calcium: a multi-institutional, multimanufacturer international standard for quantification at cardiac CT. Radiology. 2007;243(2):527\u201338.","journal-title":"Radiology"},{"issue":"4","key":"2628_CR24","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"9921","key":"2628_CR25","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","volume":"383","author":"SS Mahmood","year":"2014","unstructured":"Mahmood SS, et al. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383(9921):999\u20131008.","journal-title":"Lancet"},{"issue":"25","key":"2628_CR26","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, et al. Global Burden of Cardiovascular diseases and Risk factors, 1990\u20132019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"2628_CR27","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","volume":"389","author":"C Magnussen","year":"2023","unstructured":"Magnussen C, et al. Global effect of modifiable risk factors on Cardiovascular Disease and Mortality. N Engl J Med. 2023;389(14):1273\u201385.","journal-title":"N Engl J Med"},{"issue":"3","key":"2628_CR28","first-page":"251","volume":"31","author":"H Struijker-Boudier","year":"2009","unstructured":"Struijker-Boudier H. The burden of vascular disease in diabetes and hypertension: from micro-to macrovascular disease\u2014the bad loop. Medicographia. 2009;31(3):251\u20136.","journal-title":"Medicographia"},{"issue":"1","key":"2628_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12933-023-01982-6","volume":"22","author":"CJ \u00d6stgren","year":"2023","unstructured":"\u00d6stgren CJ, et al. Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals-a Swedish population-based study. Cardiovasc Diabetol. 2023;22(1):261.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"2628_CR30","doi-asserted-by":"publisher","first-page":"e15102","DOI":"10.1111\/dme.15102","volume":"40","author":"J Cederqvist","year":"2023","unstructured":"Cederqvist J, et al. Arterial stiffness and subclinical atherosclerosis in the coronary arteries at different stages of dysglycaemia. Diabet Med. 2023;40(7):e15102.","journal-title":"Diabet Med"},{"key":"2628_CR31","doi-asserted-by":"publisher","first-page":"27442","DOI":"10.1038\/srep27442","volume":"6","author":"W Yip","year":"2016","unstructured":"Yip W, et al. Joint effect of early microvascular damage in the eye & kidney on risk of cardiovascular events. Sci Rep. 2016;6:27442.","journal-title":"Sci Rep"},{"issue":"7","key":"2628_CR32","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.009","volume":"25","author":"VY Guo","year":"2016","unstructured":"Guo VY, et al. Prospective association between diabetic retinopathy and cardiovascular disease-a systematic review and meta-analysis of cohort studies. J Stroke Cerebrovasc Dis. 2016;25(7):1688\u201395.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"2628_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.293.1.63","volume":"293","author":"TY Wong","year":"2005","unstructured":"Wong TY, et al. Retinopathy and risk of congestive heart failure. JAMA. 2005;293(1):63\u20139.","journal-title":"JAMA"},{"issue":"12","key":"2628_CR34","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1161\/01.CIR.0000091257.27563.32","volume":"108","author":"MA Creager","year":"2003","unstructured":"Creager MA, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation. 2003;108(12):1527\u201332.","journal-title":"Circulation"},{"issue":"2","key":"2628_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2174\/157339910790909396","volume":"6","author":"K Masuo","year":"2010","unstructured":"Masuo K, et al. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. Curr Diabetes Rev. 2010;6(2):58\u201367.","journal-title":"Curr Diabetes Rev"},{"issue":"6","key":"2628_CR36","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/HYPERTENSIONAHA.117.10634","volume":"71","author":"RM Bruno","year":"2018","unstructured":"Bruno RM, et al. Age- and sex-specific reference values for Media\/Lumen ratio in small arteries and relationship with risk factors. Hypertension. 2018;71(6):1193\u2013200.","journal-title":"Hypertension"},{"issue":"6","key":"2628_CR37","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.118.11769","volume":"73","author":"RE Climie","year":"2019","unstructured":"Climie RE, et al. Macrovasculature and microvasculature at the crossroads between type 2 diabetes Mellitus and Hypertension. Hypertension. 2019;73(6):1138\u201349.","journal-title":"Hypertension"},{"issue":"12","key":"2628_CR38","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1097\/HJH.0000000000003855","volume":"42","author":"N Wang","year":"2024","unstructured":"Wang N, et al. Combination blood pressure lowering therapy in patients with type 2 diabetes: messages from the ADVANCE trial. J Hypertens. 2024;42(12):2055\u201364.","journal-title":"J Hypertens"},{"issue":"3","key":"2628_CR39","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/HYPERTENSIONAHA.121.17962","volume":"79","author":"S Laurent","year":"2022","unstructured":"Laurent S, et al. Microcirculation and macrocirculation in hypertension: a dangerous cross-link? Hypertension. 2022;79(3):479\u201390.","journal-title":"Hypertension"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02628-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02628-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02628-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:30:07Z","timestamp":1740155407000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02628-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2628"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02628-5","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Fredriksson is part-time employed by Perimed AB that is developing products related to research described in this publication","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}